Synergistic antibody induction by antigen-CD40 ligand fusion protein as improved immunogen

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Full scale B-cell activation requires not only B-cell receptor (BCR) engagement with antigen, but also costimulatory signals provided by T helper cells through the CD40-CD40 ligand (CD40L) interaction. It is hypothesized that a fusion protein of an antigen and soluble CD40L (CD40LT) would selectively target the costimulation to antigen-specific B cells, leading to synergy in the antibody response. This hypothesis was investigated by fusing green fluorescence protein (GFP), a generic antigen, with mouse CD40LT. Studies revealed that immunization in mice with the plasmid encoding GFP-CD40LT fusion protein led to synergistic induction of GFP-specific antibodies, while control plasmid(s) for GFP, CD40LT, or GFP plus CD40LT did not. Immunization with a single dose of the fusion protein also provoked a vigorous GFP-specific immunoglobulin G1 antibody response, but not other antibody isotypes. These results suggest that GFP-CD40LT fusion protein induces a GFP-specific B-cell activation and antibody response in an antigen-guided fashion. The potential application of this novel strategy in vaccine development is discussed.

Original languageEnglish
Pages (from-to)215-222
Number of pages8
JournalImmunology
Volume115
Issue number2
DOIs
StatePublished - Jun 1 2005

Fingerprint

CD40 Ligand
Antigens
Antibodies
Fluorescence
Proteins
B-Lymphocytes
Antibody Formation
Immunization
Plasmids
Helper-Inducer T-Lymphocytes
Immunoglobulins
Vaccines

Keywords

  • Antibody
  • B lymphocyte
  • CD40
  • CD40L
  • Fusion protein

ASJC Scopus subject areas

  • Immunology

Cite this

Synergistic antibody induction by antigen-CD40 ligand fusion protein as improved immunogen. / Li, Wei.

In: Immunology, Vol. 115, No. 2, 01.06.2005, p. 215-222.

Research output: Contribution to journalArticle

@article{b5d944ace27943668927ba2dfb28bf22,
title = "Synergistic antibody induction by antigen-CD40 ligand fusion protein as improved immunogen",
abstract = "Full scale B-cell activation requires not only B-cell receptor (BCR) engagement with antigen, but also costimulatory signals provided by T helper cells through the CD40-CD40 ligand (CD40L) interaction. It is hypothesized that a fusion protein of an antigen and soluble CD40L (CD40LT) would selectively target the costimulation to antigen-specific B cells, leading to synergy in the antibody response. This hypothesis was investigated by fusing green fluorescence protein (GFP), a generic antigen, with mouse CD40LT. Studies revealed that immunization in mice with the plasmid encoding GFP-CD40LT fusion protein led to synergistic induction of GFP-specific antibodies, while control plasmid(s) for GFP, CD40LT, or GFP plus CD40LT did not. Immunization with a single dose of the fusion protein also provoked a vigorous GFP-specific immunoglobulin G1 antibody response, but not other antibody isotypes. These results suggest that GFP-CD40LT fusion protein induces a GFP-specific B-cell activation and antibody response in an antigen-guided fashion. The potential application of this novel strategy in vaccine development is discussed.",
keywords = "Antibody, B lymphocyte, CD40, CD40L, Fusion protein",
author = "Wei Li",
year = "2005",
month = "6",
day = "1",
doi = "10.1111/j.1365-2567.2005.02141.x",
language = "English",
volume = "115",
pages = "215--222",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Synergistic antibody induction by antigen-CD40 ligand fusion protein as improved immunogen

AU - Li, Wei

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Full scale B-cell activation requires not only B-cell receptor (BCR) engagement with antigen, but also costimulatory signals provided by T helper cells through the CD40-CD40 ligand (CD40L) interaction. It is hypothesized that a fusion protein of an antigen and soluble CD40L (CD40LT) would selectively target the costimulation to antigen-specific B cells, leading to synergy in the antibody response. This hypothesis was investigated by fusing green fluorescence protein (GFP), a generic antigen, with mouse CD40LT. Studies revealed that immunization in mice with the plasmid encoding GFP-CD40LT fusion protein led to synergistic induction of GFP-specific antibodies, while control plasmid(s) for GFP, CD40LT, or GFP plus CD40LT did not. Immunization with a single dose of the fusion protein also provoked a vigorous GFP-specific immunoglobulin G1 antibody response, but not other antibody isotypes. These results suggest that GFP-CD40LT fusion protein induces a GFP-specific B-cell activation and antibody response in an antigen-guided fashion. The potential application of this novel strategy in vaccine development is discussed.

AB - Full scale B-cell activation requires not only B-cell receptor (BCR) engagement with antigen, but also costimulatory signals provided by T helper cells through the CD40-CD40 ligand (CD40L) interaction. It is hypothesized that a fusion protein of an antigen and soluble CD40L (CD40LT) would selectively target the costimulation to antigen-specific B cells, leading to synergy in the antibody response. This hypothesis was investigated by fusing green fluorescence protein (GFP), a generic antigen, with mouse CD40LT. Studies revealed that immunization in mice with the plasmid encoding GFP-CD40LT fusion protein led to synergistic induction of GFP-specific antibodies, while control plasmid(s) for GFP, CD40LT, or GFP plus CD40LT did not. Immunization with a single dose of the fusion protein also provoked a vigorous GFP-specific immunoglobulin G1 antibody response, but not other antibody isotypes. These results suggest that GFP-CD40LT fusion protein induces a GFP-specific B-cell activation and antibody response in an antigen-guided fashion. The potential application of this novel strategy in vaccine development is discussed.

KW - Antibody

KW - B lymphocyte

KW - CD40

KW - CD40L

KW - Fusion protein

UR - http://www.scopus.com/inward/record.url?scp=19544389509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19544389509&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2567.2005.02141.x

DO - 10.1111/j.1365-2567.2005.02141.x

M3 - Article

VL - 115

SP - 215

EP - 222

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 2

ER -